Group 1 - The Beijing Vaccine Inspection Center was officially inaugurated in Zhongguancun Life Science Park, designed to meet the annual inspection demand for 4,000 to 4,500 batches of vaccines, with capabilities for future vaccine inspections over the next 5 to 10 years [1] - The center, as the first standalone vaccine inspection project in the country, covers an area of 16,000 square meters and includes five specialized laboratories necessary for vaccine inspection, capable of covering all inspection items for Beijing-produced vaccines [1] - Beijing is a significant hub for vaccine research and production in China, with eight vaccine manufacturers accounting for over 40% of the national vaccine varieties, leading the country in vaccine supply [1] Group 2 - The Beijing Institute of Drug Control aims to enhance drug quality safety inspection efficiency and improve inspection capabilities, regulatory scientific research capabilities, and management support levels through the operation of the new vaccine inspection center [2] - The institute has already achieved full inspection capabilities for 28 vaccine varieties and has received authorization for batch release inspection of nine vaccines from the National Medical Products Administration, maintaining the top position in inspection capabilities among provinces [1]